TrialEsophagus : official journal of the Japan Esophageal Society2023

First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50).

Ken Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.